Abstract
Mesenchymal stem cells (MSCs) represent a new therapeutic paradigm for a number of diseases because they possess unique biological characteristics such as multipotency, immunomodulation and production of cytokines. Currently, 425 MSC based clinical trials have been conducted for at least 12 kinds of pathological conditions, with many completed trials demonstrating the safety and efficacy of MSCs. Here, we provide an overview of the clinical status of MSCs by searching the public clinical trials database http://clinicaltrials.gov. Particularly, the role of MSCs in clinical trials to treat bone defects and injuries is highlighted.
Keywords: Bone defects, clinical transition, differentiation, immunomodulation, mesenchymal stem cells, secretome.
Current Molecular Pharmacology
Title:Mesenchymal Stem Cells and Cell Therapy for Bone Repair
Volume: 9
Author(s): Shihua Wang, Pengchao Xu, Xiaoxia Li, Xiaodong Su, Yunfei Chen, Li Wan, Linyuan Fan, Kan Yin, Yan Liu and Robert Chunhua Zhao
Affiliation:
Keywords: Bone defects, clinical transition, differentiation, immunomodulation, mesenchymal stem cells, secretome.
Abstract: Mesenchymal stem cells (MSCs) represent a new therapeutic paradigm for a number of diseases because they possess unique biological characteristics such as multipotency, immunomodulation and production of cytokines. Currently, 425 MSC based clinical trials have been conducted for at least 12 kinds of pathological conditions, with many completed trials demonstrating the safety and efficacy of MSCs. Here, we provide an overview of the clinical status of MSCs by searching the public clinical trials database http://clinicaltrials.gov. Particularly, the role of MSCs in clinical trials to treat bone defects and injuries is highlighted.
Export Options
About this article
Cite this article as:
Wang Shihua, Xu Pengchao, Li Xiaoxia, Su Xiaodong, Chen Yunfei, Wan Li, Fan Linyuan, Yin Kan, Liu Yan and Zhao Chunhua Robert, Mesenchymal Stem Cells and Cell Therapy for Bone Repair, Current Molecular Pharmacology 2016; 9 (4) . https://dx.doi.org/10.2174/1874467208666150928153758
DOI https://dx.doi.org/10.2174/1874467208666150928153758 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Action of Prostaglandins on Ion Channels
Current Neuropharmacology Targeting Leukotrienes for the Treatment of COPD?
Inflammation & Allergy - Drug Targets (Discontinued) Pharmacogenomics of Multiple Sclerosis: Current Status and Potential Applications
Current Pharmacogenomics and Personalized Medicine Therapeutic Opportunities for Trophic Factors in Brain Inflammation
Current Pharmaceutical Analysis The Cytotoxic and Immunomodulatory Effects of Titanium Dioxide Nanoparticles and <i>Sargassum oligocystum</i> on <i>Toxoplasma gondii In Vitro</i> and <i>In Vivo</i>
Anti-Infective Agents Gene and Cancer Therapy - Pseudorabies Virus: A Novel Research and Therapeutic Tool?
Current Gene Therapy CTLA-4Ig: Uses and Future Directions
Recent Patents on Inflammation & Allergy Drug Discovery Resistance to Macrocyclic Lactones
Current Pharmaceutical Biotechnology Defining a Role for Mucosal Immunity in the Prevention and Pathogenesis of Respiratory Allergic Diseases
Current Immunology Reviews (Discontinued) Molecular Genetics and Epidemiology of Japanese Type 1 Diabetes
Current Pharmacogenomics Interleukin-4, Interleukin-13, Signal Transducer and Activator of Transcription Factor 6, and Allergic Asthma
Current Molecular Medicine Integrase Interactor 1 in Health and Disease
Current Protein & Peptide Science Pyrazoles as Promising Scaffold for the Synthesis of Anti-Inflammatory and/or Antimicrobial Agent: A Review
Mini-Reviews in Medicinal Chemistry Innate Immune Surveillance in the Central Nervous System Following Legionella pneumophila Infection
CNS & Neurological Disorders - Drug Targets Regulatory T-Cells: Immunomodulators in Health and Disease
Current Topics in Medicinal Chemistry Alzheimers Disease: From Pathogenesis to Disease-Modifying Approaches
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Cyclooxygenases and Cyclooxygenase Inhibitors in Neurological and Psychiatric Diseases (Executive Editor: Luisa Minghetti) ]
Current Pharmaceutical Design Targeting the mTOR Pathway in Tumor Malignancy
Current Cancer Drug Targets Tolfenamic Acid Prevents Amyloid β-induced Olfactory Bulb Dysfunction In Vivo
Current Alzheimer Research Second Generation Proteasome Inhibitors in Multiple Myeloma
Anti-Cancer Agents in Medicinal Chemistry